Sidonie K. Hartridge-Lambert, Heiko Schöder, Remy C. Lim, Jocelyn C. Maragulia and Carol S. Portlock ABVD alone and a PET scan complete remission negates the need for radiologic surveillance in early-stage, nonbulky Hodgkin lymphoma Cancer 119
Version of Record online: 6 NOV 2012 | DOI: 10.1002/cncr.27873
The combination of doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD) alone and a complete remission noted on positron emission tomography negate the need for radiologic surveillance in patients with early-stage, nonbulky Hodgkin lymphoma. This combination will reduce anxiety, cumulative radiation exposure, and health care costs in a predominantly young patient population.
Complete the form below and we will send an e-mail message containing a link to the selected article on your behalf
Required = Required Field